Global Biopharmaceutical Contract Manufacturing Market By Type (Growth Factors, Interferons,and Others), By Application (Autoimmune Diseases, Oncology, and Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 133962
- 12-Dec
- PDF/PPT/Word
-
Report Details
The report on Biopharmaceutical Contract Manufacturing Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global biopharmaceutical contract manufacturing market is segmented on the basis of Type, Application and geography.
The global Biopharmaceutical Contract Manufacturing market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.
Biopharmaceutical Contract Manufacturing Market Scope:
By type, the market is segmented into Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines?and Insulin. By Application, the market is divided into Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology?and Respiratory Disorders. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Lonza Group, Baxter Biopharma Solutions, Samsung, Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim, Patheon, Rentschler Biotechnologie, Biomeva, Probiogen, Cytovance Biologics, KBI Biopharma, WuXi Biologics?and Abzena.
Key Market Segments
Type
Growth Factors
Interferons
Monoclonal Antibodies
Recombinant Hormones
Vaccines
InsulinApplication
Autoimmune Diseases
Oncology
Metabolic Diseases
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Neurology
Respiratory DisordersKey Market Players included in the report:
Lonza Group
Baxter Biopharma Solutions
Samsung
Fujifilm Diosynth Biotechnologies
Boehringer Ingelheim
Patheon
Rentschler Biotechnologie
Biomeva
Probiogen
Cytovance Biologics
KBI Biopharma
WuXi Biologics
AbzenaReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Biopharmaceutical Contract Manufacturing Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Biopharmaceutical Contract Manufacturing Market, high-growth regions, and market drivers, restraints and also market chances.
The analysis covers Biopharmaceutical Contract Manufacturing Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Biopharmaceutical Contract Manufacturing Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Biopharmaceutical Contract Manufacturing Market together side their company profiles, SWOT analysis, latest advancements and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
To know the Biopharmaceutical Contract Manufacturing Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Biopharmaceutical Contract Manufacturing sub-markets, depending on key regions (various vital states).
To analyze Biopharmaceutical Contract Manufacturing Market concerning growth trends, prospects and also their participation in the entire sector.
To examine and study the Biopharmaceutical Contract Manufacturing Market size (volume & value) from the company, essential regions/countries, products and Application, background information from 2012 to 2018 and also prediction to 2028.
Primary worldwide Biopharmaceutical Contract Manufacturing Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market. -
Table Of Content
1. Biopharmaceutical Contract Manufacturing Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Biopharmaceutical Contract Manufacturing Market Overview3.1. Biopharmaceutical Contract Manufacturing Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map4. Global Biopharmaceutical Contract Manufacturing Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Biopharmaceutical Contract Manufacturing Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Growth Factors
4.4. Interferons
4.5. Monoclonal Antibodies
4.6. Recombinant Hormones
4.7. Vaccines
4.8. Insulin5. Global Biopharmaceutical Contract Manufacturing Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-20285.1. Global Biopharmaceutical Contract Manufacturing Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Autoimmune Diseases
5.4. Oncology
5.5. Metabolic Diseases
5.6. Ophthalmology
5.7. Cardiovascular Diseases
5.8. Infectious Diseases
5.9. Neurology
5.10. Respiratory Disorders6. Global Biopharmaceutical Contract Manufacturing Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-20286.1. North America
6.1.1. North America Biopharmaceutical Contract Manufacturing Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2. Europe
6.2.1. Europe Biopharmaceutical Contract Manufacturing Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Biopharmaceutical Contract Manufacturing Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia6.4. Latin America
6.4.1. Latin America Biopharmaceutical Contract Manufacturing Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Biopharmaceutical Contract Manufacturing Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Biopharmaceutical Contract Manufacturing Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Lonza Group7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. Baxter Biopharma Solutions7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Samsung7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Fujifilm Diosynth Biotechnologies7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Boehringer Ingelheim7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. Patheon7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Rentschler Biotechnologie7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. Biomeva7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Probiogen7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments7.12. Cytovance Biologics7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments7.13. KBI Biopharma7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments7.14. WuXi Biologics7.14.1. Company Overview
7.14.2. Financial Highlights
7.14.3. Product Portfolio
7.14.4. SWOT Analysis
7.14.5. Key Strategies and Developments7.15. Abzena7.15.1. Company Overview
7.15.2. Financial Highlights
7.15.3. Product Portfolio
7.15.4. SWOT Analysis
7.15.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
